Home Cart Sign in  
Chemical Structure| 2377576-35-5 Chemical Structure| 2377576-35-5

Structure of BAY-3827
CAS No.: 2377576-35-5

Chemical Structure| 2377576-35-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY-3827 is an AMPK inhibitor that can influence energy metabolism, with potential application value in metabolic disease and cancer research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAY-3827

CAS No. :2377576-35-5
Formula : C27H25FN6O
M.W : 468.53
SMILES Code : O=C(NC1=NNC2=C1C=C(C3C(C#N)=C(C)N(C)C(C)=C3C#N)C(F)=C2C)C4=CC=CC=C4CC
MDL No. :MFCD34662962

Safety of BAY-3827

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of BAY-3827

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U2OS cells 260 nM 30 minutes Inhibition of phosphorylation of AMPK downstream targets, including ACC, Raptor, and GBF1 PMC10778976
Primary skeletal muscle cells 5 μM 1 hour To evaluate the inhibitory effect of BAY-3827 on lactate-induced NOS1 Ser1417 phosphorylation. Results showed that BAY-3827 significantly reduced lactate-induced NOS1 Ser1417 phosphorylation levels. PMC11577611

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD-SCID mice Oral gavage 10 mg/kg Single dose Evaluation of BAY-3827 bioavailability, showing low oral bioavailability PMC10778976
C57BL/6J mice NTRK1-knockdown model Brain stereotactic injection 5 µL per mouse Single injection, maintained for two weeks BAY-3827 exacerbated the depressive-like behavior induced by NTRK1 knockdown PMC10618268

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.67mL

2.13mL

1.07mL

21.34mL

4.27mL

2.13mL

References

 

Historical Records

Categories